HK1159507A1 - Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient - Google Patents

Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient

Info

Publication number
HK1159507A1
HK1159507A1 HK12100054.9A HK12100054A HK1159507A1 HK 1159507 A1 HK1159507 A1 HK 1159507A1 HK 12100054 A HK12100054 A HK 12100054A HK 1159507 A1 HK1159507 A1 HK 1159507A1
Authority
HK
Hong Kong
Prior art keywords
agent
fatigue
amino acid
active ingredient
acid composition
Prior art date
Application number
HK12100054.9A
Inventor
Hiroyuki Arita
Masako Tsunematsu
Hiroshi Echizen
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of HK1159507A1 publication Critical patent/HK1159507A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK12100054.9A 2008-10-06 2012-01-04 Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient HK1159507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008259678 2008-10-06
PCT/JP2009/067387 WO2010041647A1 (en) 2008-10-06 2009-10-06 Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient

Publications (1)

Publication Number Publication Date
HK1159507A1 true HK1159507A1 (en) 2012-08-03

Family

ID=42100597

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12100054.9A HK1159507A1 (en) 2008-10-06 2012-01-04 Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient

Country Status (4)

Country Link
JP (1) JPWO2010041647A1 (en)
CN (1) CN102170876B (en)
HK (1) HK1159507A1 (en)
WO (1) WO2010041647A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311061A (en) * 2014-05-31 2016-02-10 陈光健 Pharmaceutical composition having wound surface healing effect, preparation method and applications thereof
JP6496599B2 (en) * 2014-06-13 2019-04-03 花王株式会社 Muscle protein synthesis signal activator
CN105192810A (en) * 2015-10-29 2015-12-30 常州亚当生物技术有限公司 Compound amino acid beverage as well as preparation method and application thereof
CN105640995A (en) * 2016-03-01 2016-06-08 四川好医生攀西药业有限责任公司 Pharmaceutical composition and applications thereof
JP2017088616A (en) * 2017-02-09 2017-05-25 株式会社東洋新薬 Kaempferia parviflora-containing compositions
US10413563B2 (en) * 2017-05-10 2019-09-17 Emerald Neuro-Recover, LLC Neurochemical wellness program
JP7275499B2 (en) * 2018-08-27 2023-05-18 味の素株式会社 Composition for improving brain function
WO2020045612A1 (en) * 2018-08-31 2020-03-05 味の素株式会社 INTERMITTENT ENDURANCE IMPROVING AGENT OR BLOOD pH ELEVATING AGENT

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2518692B2 (en) * 1989-06-14 1996-07-24 理化学研究所 Muscle maintenance agent, nutrient tonic, infusion agent, nutritional supplement, fatigue recovery agent and lactic acid production regulator
JP2873497B2 (en) * 1990-09-03 1999-03-24 理化学研究所 Lipid metabolism regulator
JP3128318B2 (en) * 1992-03-18 2001-01-29 株式会社クラレ Method for producing cationic dye dyeable polyester microfiber
JPWO2003011056A1 (en) * 2001-07-31 2004-11-18 味の素株式会社 Food composition for recovery from fatigue
JP4528925B2 (en) * 2003-05-30 2010-08-25 独立行政法人理化学研究所 Amino acid composition and fluid replacement
US20080114067A1 (en) * 2005-01-31 2008-05-15 Takanobu Yamamoto Composition for Recovery From or Prevention of Central Nervous System Fatigue
JP5764281B2 (en) * 2006-06-08 2015-08-19 株式会社明治 Blood fluidity improver
CN101454000A (en) * 2006-06-13 2009-06-10 明治乳业株式会社 Anti-fatigue agent containing amino acid composition
JP5812565B2 (en) * 2007-02-28 2015-11-17 株式会社明治 Amino acid composition

Also Published As

Publication number Publication date
CN102170876B (en) 2013-12-04
CN102170876A (en) 2011-08-31
JPWO2010041647A1 (en) 2012-03-08
WO2010041647A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
HK1159507A1 (en) Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient
HRP20181353T1 (en) The tuberculosis rv2386c protein, compositions and uses thereof
HUS2000039I1 (en) Herbicidal compositions comprising 4-amino-3,6-dichloropyridine-2-carboxylic acid
SG10202105126SA (en) Compositions comprising 1,1,1,2,3-pentafluoropropane or 2,3,3,3- tetrafluoropropene
IL206395A (en) N-heterocyclyl-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamides and pharmaceutical compositions comprising them
IL211762A0 (en) Pegylated opiods, compositions comprising the same and uses thereof
ZA201103584B (en) Whey protein compositions,methods and uses
HK1134029A1 (en) Amino acid composition
PL2588556T3 (en) Composition comprising 2,3,3,3-tetrafluoropropene
HK1149007A1 (en) Amide compounds, compositions and uses thereof
IL212559A0 (en) Oxidatitive photoactivated skin rejuvenation composition comprising hyaluronic acid, glucosamine. or allatoin
IL203099A (en) Optically active (r)-aryloxypropionic acid amides, processes for their preparation and herbicidal compositions comprising the same
ZA201008180B (en) Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
WO2010077898A3 (en) Trans-chloro-3,3,3-trifluoropropene for use in chiller applications
WO2009043353A3 (en) Micromirs
AP2010005380A0 (en) Extracellular matrix compositions.
IL197185A (en) Substituted acylanilide, composition comprising it and uses thereof
EP2513023A4 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
EP2210601A4 (en) Anti-fatigue agent comprising amino acid composition
EP2303920A4 (en) AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES
IL220284A0 (en) Insulin analogues with chlorinated amino acids, compositions comprising the same and uses thereof
IL206531A0 (en) Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
IL213748A0 (en) Cell adhesion inhibiting peptides, compositions comprising the same and uses thereof
EP2366691A4 (en) The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
ZA201006717B (en) Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191004